A new legislation has been introduced to allow authorised pharmacists along with other healthcare professionals in Northern Ireland to certify 'fit notes',
health minister Robin Swann has announced.
Pharmacists and some other healthcare professionals in England, Scotland and Wales are already allowed to sign 'fit notes'.
Swann announced that 'fit notes' were also set to go fully digital in the future, meaning they would no longer need to be signed in ink.
He said: "I am delighted to introduce this legislation in Northern Ireland. This change will make it easier for people and employers to get the advice they need so
people can stay in work and will help free up doctors' time.
"Too often we see people being faced with unnecessary challenges to get a fit note. More professionals being able to offer this vital service will speed up the
process and support people to return to or remain in work."
Whether it's the effects of the coronavirus pandemic and those suffering with long Covid, or the financial pressures of rising living costs, these hard times
can affect absolutely anyone's mental health.
Mental health problems have worsened across all age-groups in the last few years, from lack of social interaction, unexpected bereavements or the significant impact
of a physical injury or long-term illness taking its toll on mental wellbeing - these challenging experiences and situations that we face throughout life leave a
big strain on the population.
Ultimately, there is an urgent need to reduce rising levels of mental ill-health in our society. As a pharmacist with 25 years' experience in healthcare, I feel I
have an obligation to my patients to support them with their healthcare needs, and mental health should be treated just the same as physical health.
Despite efforts to improve NHS mental health services, patients may still not be receiving the appropriate immediate care as they are often provided with online
counselling or an App for long-term support (online support introduced since the pandemic).
Community pharmacists are in a unique position to be advocates for patients with mental illness as they are the healthcare professionals' patients see most often.
This is a good opportunity for pharmacists to speak to patients face-to-face and give them advice in a more practical way rather than potentially waiting weeks for
an GP appointment.
The Scottish government has appointed Christina McKelvie MSP as the new Minister for Drugs and Alcohol policy, following the resignation of Elena
Whitham MSP due to health reasons.
In a letter to the First Minister, Whitham said she was receiving treatment for post-traumatic stress, which had "greatly" affected her wellbeing.
Commenting on the news, Royal Pharmaceutical Society (RPS) Scotland thanked Whitham for supporting them, particularly for her "efforts to bring in a new
national service to provide emergency access to supplies of naloxone."
RPS Scotland has continuously advocated for the accessibility of naloxone through all community pharmacies (for supply to people who use drugs, family, healthcare
professionals and carers), and to make it available in all clinical settings for use in emergencies.
It was also the top recommendation of their policy on Pharmacy's role in reducing harm and preventing drug deaths.
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients and consumers on a number of subjects including the use of dietary supplements.
Their role in the sale of and advice regarding natural health and drug alternatives has never been more relevant. The recent National Health Service (NHS) Interim
People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists as a critical part of multidisciplinary teams,
providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of taking control, which the prescription process often denies them.
The vast and growing depository of information on the internet is certainly fuelling this, but as much of this is brand derived content, information, it can often be generic with a 'one size fits all' marketing message.
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients
and consumers on a number of subjects including the use of dietary supplements. Their role in the sale of and advice regarding natural health and drug alternatives
has never been more relevant.
The recent National Health Service (NHS) Interim People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists
as a critical part of multidisciplinary teams, providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of
taking control, which the prescription process often denies them.
Historically the immense benefits provided by the NHS have instilled a general abdication of our personal health control, leaving us to rely on the health service
to treat and cure as necessary.
As our NHS has become visibly over-stretched we begin to realise what the rest of the world has known for centuries - good health is based primarily upon nutritional
robustness. It may be stating the obvious but there is an excellent source of incremental revenue for the pharmacist who is willing to provide space to and advice
for nutritional supplements.
The Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have authorised community pharmacies
throughout the UK to dispense original full packs of Valproate-containing medicines upon prescription.
The necessary changes in regulations came into effect on 11 October which was strongly supported by 85 per cent of respondents concerned about risks to the
unborn baby if valproate-containing medicines are used in pregnancy.
The decision was made to ensure patients receive safety warnings and pictograms, including a patient card and the Patient Information Leaflet (PIL), contained
in the manufacturer's original full pack.
Valproate is a treatment for epilepsy and bipolar disorder but is also associated with birth defects and neurological disabilities.
To combat the effects of climate change, the Integrated Care System (ICS) in South East London (SEL) has initiated a pioneering inhaler recycling project.
Supported by NHS England and spanning 20 community pharmacies across the region, the project marks the first nationally-funded pilot of its kind in England,
targeting the reduction of greenhouse gas emissions from improperly disposed inhalers.
The project, which commenced at King's College Hospital in February 2024, focuses on the recycling of pressurised metered-dose inhalers.
These inhalers, due to their propellant content, contribute significantly to environmental harm, emitting gases equivalent to driving 71.8 miles in a standard
petrol car.
The #AskAboutAsthma annual campaign, led by NHS England - London's Babies, Children and Young People programme, is returning for its eighth year with a
focus on promoting simple changes that can make a big difference to people living with asthma.
Scheduled to take place from 9-15 September, this year' campaign aims to address broader factors such as vaping, air quality, housing conditions, and mould to
ensure every child and young person in London with asthma receives the support and tools necessary to manage their condition effectively.
Pharmacists are encouraged to support the 2024 #AskAboutAsthma campaign, themed "helping children and young people with asthma to live their best lives." They
can contribute to the campaign in various ways, including:
Offering inhaler technique checks to all children and young people with asthma.
Identifying children and young people who are not regularly collecting their preventer medication and communicating this to their GP practice.
Identifying children and young people who are collecting large amounts of reliever medication and communicating this to their GP practice.
A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals.
The study also found a strong public willingness to pay higher taxes to enhance NHS services.
The Health Foundation and Ipsos UK conducted the research, combining nationwide polling with in-depth public deliberative workshops.
These workshops, held in King's Lynn, Leeds, and London, constitute one of the most comprehensive public consultations about the future of the NHS in England.
The study published on 16 May underscores the public's desire for a redistribution of NHS resources. If the NHS budget remains unchanged, 60 per cent of those
polled believe the government should focus on improving access to community-based services like general practice and dentistry.
Members of the Pharmacists' Defence Association (PDA) who have benefits in the Boots Pension Scheme have sought support from their union following the recent
communications from the trustees about the removal of the option to retire at 60 without a reduced pension.
The company claimed that retirement between 60-65 years old without a reduced pension was a discretionary benefit, and it has ended with the buy-in deal with Legal
and General.
However, PDA members believe there is insufficient evidence to fully support this claim, and therefore they are questioning whether this option should have been
secured as part of the buy in and not ended with immediate effect.
PDA Union national officer, Paul Moloney said: "Instead, we believe benefit statements issued to members, at the very least are contradictory, and clearly state
that a full pension will be payable from a member's 60th birthday, with no reference to this benefit being discretionary and therefore subject to a regular
review by the trustees. Instead, the benefit statements give the impression that an unreduced pension from 60 is a right with no indication that retirement plans
should not be based on the benefit statements."
The Pharmacists' Defence Association (PDA) has reiterated its call for all pharmacists working at Boots to join the PDA Union to support the collective voice of the profession within the company.
It said this would enable PDA to send direct communications to pharmacists working at Boots and keep them up to date with key matters impacting their work life.
Currently, the association uses the company communication channels to cascade key information to the non-member pharmacists, however, it fears such measures can be
disrupted by management.
Besides, having more member pharmacists at Boots would strengthen their "negotiating power", PDA said.
The Royal Pharmaceutical Society (RPS) has welcomed the Health Secretary Sajid Javid's plan to appoint Hormone Replacement Therapy (HRT) tsar to tackle the medicine shortages.
On Sunday (April 24) Sajid Javid told the Mail that he planned to tackle the problem (shortage of HRT medicine) by appointing a new HRT tsar with the role modelled on that of Kate Bingham, who successfully led the government's Covid vaccine taskforce.
"The difficulties in accessing HRT medicine have unfairly impacted women's mental health," said RPS President, Professor Claire Anderson.
"I look forward to working with this new champion for HRT and the Government on how we can better support women's health, building on the positive move to reduce
prescription charges for HRT for women."
Anderson also stressed that "the Government should now go further and end unfair prescription charges for patients in England altogether."
French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step
of its plan to increase access to its medicines worldwide.
The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business.
The plan also includes the $25 million Impact fund, which will go towards supporting local start-up healthcare businesses and providing training on using the
medicines, Sanofi said.
"There's a lot of noise at the moment from different companies jumping into this space… but investing in entrepreneurship, in the ecosystem, is a new thing," said
Jon Fairest, who heads the global health unit.
The treatments available are on the World Health Organization's essential medicines list, and insulin in particular has been singled out by the UN agency as a
life-saving medicine for diabetics that is difficult to access in many lower-income countries, where the burden of disease is growing.
Senior academic pharmacist, Professor Mahendra Patel, recently received an award for his outstanding contribution and support for the Nigerian community
in the UK.
The Medical Association of Nigerians across GB (MANSAG) conducted its two-day annual General and Scientific Conference on October 27 and 28 in London.
The theme of the conference focussed on "Transforming Health Outcomes" to celebrate the contributions Nigerian doctors make to healthcare systems in the UK and
globally.
Dr Patel delivered an encouraging speech on "Leading Black And Minority Ethnic Population Research by BAME Researchers".
Being aware of and understanding our mental health is extremely important. Mental health is not simply a medical condition, it essentially encompasses our
psychological and emotional well-being.
Mental health awareness has increased in recent years, however, since the COVID-19 pandemic, awareness of our mental stability and how we process our feelings
has become all too apparent. It is important that we all learn to be open with our feelings and also be able to support others who may be struggling with their
own mental health.
The World Health Organisation (WHO) conceptualises mental health as a "state of well-being in which the individual realises his or her own abilities, can cope
with the normal stresses of work productively and fruitfully, and is able to make a contribution to his or her community."
Maintaining a healthy digestive system is a vital component of a customer's overall health. Gut health affects how food is processed and digested, in turn affecting how and what vitamins and minerals are absorbed from the food that is ingested. It also impacts immune system efficiencies which can lead to allergies and autoimmune conditions.
As such, supporting customers with their digestive health should be a key focus for community pharmacists. Alongside offering a range of over-the-counter products,
pharmacists are well placed to offer one-to-one guidance for customers concerned about their digestive health. Top tips that pharmacists should provide their customers with, include:
Eating well
Pre and probiotics
Water intake
Smoking cessation
Alcohol Intake
Addiction is a complex and multifaceted condition that can significantly impact an individual's physical, emotional, and psychological well-being. Despite
the strong desire to overcome addiction, many people struggle to achieve lasting recovery on their own. Professional help is crucial in addiction treatment because
it offers specialized knowledge, comprehensive care, and evidence-based approaches tailored to each individual's needs. With the support of trained professionals,
individuals are more likely to develop the skills and strategies necessary to achieve and maintain long-term sobriety.
Understanding the Nature of Addiction
Addiction is often misunderstood as merely a lack of willpower or moral failing. However, it is recognized by the medical community as a chronic disease that
affects the brain's reward, motivation, and memory functions. These changes make it exceedingly challenging for individuals to control their substance use, even
when facing adverse consequences.
Through professional assessment, clinicians can identify the specific nature and extent of the addiction. This involves understanding the types of substances
used, frequency, and the presence of co-occurring mental health conditions. Accurate diagnosis is essential for developing a tailored treatment plan that addresses
all aspects of the individual's condition. The people behind https://healtreatmentcenters.com/resources/ note that there are many treatment centers and support
groups available to help people with addiction. It takes the expertise of professionals to properly diagnose and treat addiction effectively.
Reena Mehta, consultant pharmacist in the Critical Care team at NHS King's College Hospital, has been announced as chair of the Learning Division for the
Intensive Care Society.
Mehta took up the post with effect from 8th April, and is the first pharmacist to hold the role of Chair of the Learning Division within the Society.
"It is a privilege to be part of the Society and support its life-saving work to enhance our understanding of critical illness and deliver better care to patients,"
"The intensive care community is made up of multiple professions, each playing a vital role within the critical care team, and I am extremely proud to be the first
pharmacist appointed to this important role."
In her role as chair of the Learning Division, Mehta will oversee the content of the Society's study days and be responsible for exploring new opportunities for the
Intensive Care Society to provide training for our multi professional intensive care community.
NHS West Yorkshire Integrated Care Board (ICB)'s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale
has disappointed Coeliac UK.
In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised "grave concerns" about the decision,
warning that it will have a detrimental impact on the coeliac community.
The policy is currently implemented across the ICB's other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac
patients from accessing gluten free bread and flour mix on prescription.
NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places.
But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the
only treatment for the condition.